Rafael Rosell

机构：Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

发表论文 1002 篇 · 总被引 47354 次 · h-index 95

代表论文

• Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions (2025 · Nature Reviews Clinical Oncology · 被引 51)
• Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study (2025 · Annals of Oncology · 被引 20)
• Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial (2025 · Nature Communications · 被引 6)
• Efficacy in patients with EGFR -positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050 (2024 · Future Oncology · 被引 5)
• Novel DNA Repair Inhibitors Targeting XPG to Enhance Cisplatin Therapy in Non-Small Cell Lung Cancer: Insights from In Silico and Cell-Based Studies (2024 · Cancers · 被引 5)
• Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors (2024 · International Journal of Molecular Sciences · 被引 4)